Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer
Clinical trial NCT02588105 · COMPLETED
Trial details
- NCT number
- NCT02588105
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-10
- Primary completion
- 2019-09-13
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.